Home  |  Contact

UniProtKB/Swiss-Prot P53634: Variant p.Gln286Arg

Dipeptidyl peptidase 1
Gene: CTSC
Variant information

Variant position:  286
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glutamine (Q) to Arginine (R) at position 286 (Q286R, p.Gln286Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (Q) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HMS and PLS.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  286
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  463
The length of the canonical sequence.

Location on the sequence:   MLEARIRILTNNSQTPILSP  Q EVVSCSQYAQGCEGGFPYLI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLI

Mouse                         MLEARIRILTNNSQTPILSPQEVVSCSPYAQGCDGGFPYLI

Rat                           MLEARIRILTNNSQTPILSPQEVVSCSPYAQGCDGGFPYLI

Bovine                        MMEARIRILTNNTQTPILSPQEVVSCSQYAQGCEGGFPYLI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 231 – 394 Dipeptidyl peptidase 1 heavy chain
Binding site 302 – 302 Chloride
Binding site 304 – 304 Chloride; via amide nitrogen
Glycosylation 276 – 276 N-linked (GlcNAc...) asparagine
Disulfide bond 255 – 298
Alternative sequence 138 – 463 Missing. In isoform 2.
Alternative sequence 142 – 463 Missing. In isoform 3.
Helix 285 – 291


Literature citations

Cathepsin C gene: first compound heterozygous patient with Papillon-Lefevre syndrome and a novel symptomless mutation.
Allende L.M.; Garcia-Perez M.A.; Moreno A.; Corell A.; Carasol M.; Martinez-Canut P.; Arnaiz-Villena A.;
Hum. Mutat. 17:152-153(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS PLS TYR-236; ARG-286 AND TYR-291; VARIANT THR-153;

Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C.
Hart T.C.; Hart P.S.; Michalec M.D.; Zhang Y.; Firatli E.; Van Dyke T.E.; Stabholz A.; Zlotogorski A.; Shapira L.; Soskolne W.A.;
J. Med. Genet. 37:88-94(2000)
Cited for: VARIANT HMS ARG-286;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.